Showing results (2401-2410 of 6,521) with videos related to

Sort By:
Pageof 653
World Journal of Urology|June 21, 2022
Nurse-led coordinated surgical care pathways for cost optimization of robotic-assisted partial nephrectomy: medico-economic analysis of the UroCCR-25 AMBU-REIN studyJean-Christophe Bernhard, Grégoire Robert, Solène Ricard, et al.
World Journal of Urology|June 21, 2022
Ureteroscopy with thulium fiber laser lithotripsy results in shorter operating times and large cost savingsJames R Ryan, Mitchell H Nguyen, Joshua A Linscott, et al.
World Journal of Urology|June 25, 2022
Comparison of renal parenchymal trauma after standard, mini and ultra-mini percutaneous tract dilation in porcine modelsConstantinos Adamou, Arman Tsaturyan, Christina Kalogeropoulou, et al.
World Journal of Urology|June 30, 2022
Prospective comparison of tadalafil 5 mg alone, silodosin 8 mg alone, and the combination of both in treatment of lower urinary tract symptoms related to benign prostatic hyperplasiaMostafa AbdelRazek, Ahmad Abolyosr, Omar Mhammed, et al.
World Journal of Urology|July 1, 2022
Sex differences in treatment patterns for non-advanced muscle-invasive bladder cancer: a descriptive analysis of 3484 patients of the Netherlands Cancer RegistryAnke Richters, Anna M Leliveld, Catharina A Goossens-Laan, et al.
World Journal of Urology|January 8, 2021
Clinical, surgical, pathological and follow-up features of kidney cancer patients with Von Hippel-Lindau syndrome: novel insights from a large consortiumUmberto Capitanio, Giuseppe Rosiello, Selcuk Erdem, et al.
World Journal of Urology|January 6, 2021
Evaluating outcomes of complete supine percutaneous nephrolithotomy for staghorn vs multiple non-staghorn renal stones: a 10-year studyReza Falahatkar, Tamkin Shahraki, Siavash Falahatkar, et al.
World Journal of Urology|January 12, 2021
Should Grade Group 1 (GG1) be called cancer?Craig V Labbate, Gladell P Paner, Scott E Eggener
World Journal of Urology|February 23, 2020
Super early detailed assessment of lower urinary tract symptoms after holmium laser enucleation of the prostate (HoLEP): a prospective studySascha A Ahyai, Irina Marik, Tim A Ludwig, et al.
World Journal of Urology|February 24, 2020
Prospective evaluation of fexapotide triflutate injection treatment of Grade Group 1 prostate cancer: 4-year resultsNeal Shore, Steven A Kaplan, Ronald Tutrone, et al.
Pageof 653